Back to search results

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumor · Unresectable Solid Tumor · Metastatic Solid Tumor · Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Haley Ellis, MD) · hellis@mgh.harvard.edu · 617-724-4000
    Contact: Principal Investigator (Haley Ellis, MD)
Study leads

  • Haley Ellis, MD

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)